Antimicrobial resistance in clinical Escherichia coli isolates from poultry and livestock, China

PLoS One. 2017 Sep 21;12(9):e0185326. doi: 10.1371/journal.pone.0185326. eCollection 2017.

Abstract

Poultry and livestock are the most important reservoirs for pathogenic Escherichia coli and use of antimicrobials in animal farming is considered the most important factor promoting the emergence, selection and dissemination of antimicrobial-resistant microorganisms. The aim of our study was to investigate antimicrobial resistance in E. coli isolated from food animals in Jiangsu, China. The disc diffusion method was used to determine susceptibility to 18 antimicrobial agents in 862 clinical isolates collected from chickens, ducks, pigs, and cows between 2004 and 2012. Overall, 94% of the isolates showed resistance to at least one drug with 83% being resistance to at least three different classes of antimicrobials. The isolates from the different species were most commonly resistant to tetracycline, nalidixic acid, sulfamethoxazole, trimethoprim/sulfamethoxazole and ampicillin, and showed increasing resistance to amikacin, aztreonam, ceftazidime, cefotaxime, chloramphenicol, ciprofloxacin. They were least resistant to amoxicillin/clavulanic acid (3.4%) and ertapenem (0.2%). MDR was most common in isolates from ducks (44/44, 100%), followed by chickens (568/644, 88.2%), pigs (93/113, 82.3%) and cows (13/61, 21.3%). Our finding that clinical E. coli isolates from poultry and livestock are commonly resistant to multiple antibiotics should alert public health and veterinary authorities to limit and rationalize antimicrobial use in China.

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology*
  • China
  • Drug Resistance, Bacterial*
  • Escherichia coli / drug effects*
  • Escherichia coli / isolation & purification
  • Livestock / microbiology*
  • Microbial Sensitivity Tests
  • Poultry / microbiology*

Substances

  • Anti-Bacterial Agents

Grants and funding

This project is funded by the National Key R & D Program of China (2016YFD0500804). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.